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Medication Reconciliation – Call for Focus
Saharish Nazar, Manager Pharmacy Services
Medication reconciliation is the process of identifying the most accurate list of 
all medications that the patient is taking, including name, dosage, frequency, and 
route, by comparing the medical record to an external list of medications obtained 
from a patient, hospital, or other provider.
Preventing medications harms, or adverse drug events (ADEs), remains a top 
patient safety priority across the continuum of care for patients specially in the 
hospital. Medication history can be taken in a variety of settings such as the 
emergency department, upon Inpatient admission in ward or during a clinic visit. 
No matter what the setting is, the steps to take complete and accurate medication 
history are the same with the goal of providing correct medications to the patient 
and preventing ADEs at all transition points within the hospital.
Medication Reconciliation at AKUH mandates to record at least the below 
information: Medication Name, Dose, Frequency and Route. Taking a best possible 
medication history is essential. Key points to remember:
 1. Interview patients/ caregiver wherever possible.
 2. Remember most patients vary from their prescribed regimen. This 
  may or may not be intentional.
 3. Remember to ask about over the counter, herbal or complimentary   
  medications. 
	 4.	 Confirm	the	medicine	list	with	one	or	more	sources	of	information,		 	
  if possible e.g., previous Rx.
 5. Check a medication reference if you are unsure about a certain    
  medicine.
 6. Correctly document & transcribe the medication history.
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Step no.  Step description
1.  Develop a comprehensive list of all current 
 medications.
2. Develop  a list of medications to be prescribed.
3. Compare original and updated medication lists.
4. Make clinical decisions pertaining to what 
 medications should be continued.
5. Communicate the new medication information to  
 patient and patient’s caregiver.
Source: Reference 12.
The Joint Comission’s 5 Step Process to Conduct 
Medication Reconcilitaion
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Medication Errors | Look alike, Sound alike & Read alike 
Bilal Ahmad, Pharmacist 
The existence of confusing drug names is one of the most common causes of medication error and is of concern worldwide. 
Contributing to this confusion are illegible handwriting, incomplete knowledge of drug names, newly available products, 
similar packaging or labeling, similar clinical use, similar strengths, dosage 
forms, frequency of administration, and the failure of manufacturers and 
regulatory authorities to recognize the potential for error . The Institute for 
Safe Medication Practices (ISMP) has reported over 1,000 drug pairs of 
confusing drug names.
A 12 year old child presented to emergency department with sign and symptoms of nausea, vomiting and diarrhea. 
During the history and medication reconciliation, it was found that the child was talking tablets (Lithium carbonate), 
Neurolith SR ® from last 1  week instead of  Tablet Neurobion(Vitamin B1, B6 and B12) that was actually precribed by 
the physician.
Neurolith ® (litium Carbonate) was wrongly dispensed as a READALIKE drug with Neurobion®.  (Vitamin B1, B6 and 
B12) .
The drug, lithium carbonate usually cause mucosal irritation and hence lead to Nausea, vomiting and gastrointestinal 
symtpoms. There were no CNS manifestations along with abnormal gait.
NeuroBION®
(Vitamin B1, B6, B12)
NeuroLITH SR®
(Lithium Carbonate)
Significant damage could occur if the two medicines are interchanged. 
While the patient given neuroBION® instead of neuroLITH® might not any 
show adverse effects but exacerbation of the existing condition is possible. 
Similarly, serious harm could occur if the patient is given neuroLITH® 
instead of neuroBION®.Lithium toxicity might occur Patients with acute 
lithium toxicity often present with symptoms of nausea, vomiting, and 
diarrhea; neurological findings develop late in acute poisoning hence, 
monitoring of lithium levels would be necessary.
l Vitamin B complex. l Used for bipolar disorder.
l Available in injection and tablet form. l Available as 400mg tablets.
l Can be taken as per need basis depending on the l Usual adult dosing is 600-900mg/day in 2 to 3  
	 deficiency.	 	 divided	doses.
l Tablet form can be obtained without prescription. l Can be obtained only with valid prescription.
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Drug Interaction Corner: Benzodiazepine & Opioids
Faqeeha Shakeel, Pharmacist 
WHO and FDA reminded that Benzodiazepines when co-administered with opioids can depress the central nervous system (CNS) 
which	results	in	serious	side	effects,	difficulty	in	breathing	/	respiratory	distress,	which	may	lead	to	death.
Opioids are used to treat pain and cough; benzodiazepines are used to treat anxiety, insomnia, and seizures, when co-
prescribed,	additive	effects	on	the	central	nervous	system	increase	the	risks	of	sedation,	respiratory	depression,	coma	and	
death. Use of opioids and benzodiazepine should not be used commonly instead of the common use; professionals should 
reserve concomitant prescribing of opioid analgesics with benzodiazepines or other CNS depressants for use in patients 
for whom alternative treatment options are inadequate. If an opioid analgesic is initiated in a patient who is already on 
a benzodiazepine, prescribe a lower initial dose of the opioid, and titrate based on clinical response. Patient should be 
monitored closely for respiratory depression. 
Proper counselling should be done to the care givers / patients who are concomitantly on opioids and benzodiazepine related 
to respiratory depression.
References:
World Health Organization. WHO Pharmaceutical Newsletter. April, 2020 [Internet]. Edition no. 3. 
What Do We Need to Know about Remdesivir
Syeda Muniba Naqvi, Trainee Pharmacist
Rationale and FDA Approval
Although the US Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) to permit the 
emergency use of Remdesivir in hospitalized adult and pediatric patients irrespective of disease severity. Now, it has been 
approved by FDA.
Posology
200 mg as a single dose on day 1, followed by 100 mg once daily for 4 days in adult patients not requiring mechanical 
ventilation/extracorporeal	membrane	oxygenation	(ECMO)	or	until	hospital	discharge,	whichever	is	first	and	may	continue	
for 5 more days if clinical improvement is not observed. A 10 day therapy is suggested for patients requiring invasive 
mechanical ventilation/ECMO. The dosing remains same for children/adolescents weighing 40 kg and above. In infants/
children weighing between 3.5 kg and 40 kg; 5mg/kg/dose on day 1 is followed by 2.5mg/kg/dose once daily.
Adverse Effects and Safety Concerns
Elevated levels of Transaminase and Aminotransferase have been reported hence monitoring of hepatic enzymes is required prior 
to and during therapy. Infusion-related hypersensitivity and anaphylactic reactions have also been reported.
Administration Guidelines
DRAP approved Remdesivir 100mg lyophilized powder for infusion is being used for treatment of Covid’19 patients in 
Pakistan.	The	powder	needs	to	be	first	reconstituted	with	sterile	water	for	injection	and	then	diluted	for	infusion	with	normal	
saline. Its compatibility with other solutions has not yet been tested. A 100mg vial is to be reconstituted with 19ml sterile water 
for injection to make 20ml of 5mg/ml solution followed by shaking for 30 seconds then allowing to rest for 2 to 3 min. The 
solution is then further diluted with normal saline up to a total volume of 100 or 250 ml for infusion. For adequate mixing the 
infusion bag should be gently inverted 20 times instead of shaking. After dilution the 100ml and 250ml solution can be infused 
over 30 to 120 min. The reconstituted/diluted drug is stable for 4 hours at room temperature (20 to 25 C) and for 24 hours 
in refrigerator (2 to 8 C). Remdesivir should not be co-administered with other IV drug solutions because of unestablished 
compatibility. 
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The Aga Khan University Hospital, Karachi
Provide us your Valuable Feedback!
To keep the Pharmacy Newsletter of Aga Khan University Hospital (AKUH) updated we would like to take your valuable feedback. We are grateful 
to you for sparing few minutes of your precious time to complete form by below online link or form can be emailed to you as well. Just drop us an 
email with subject Newsletter Feedback. Email us at:drug.information@aku.edu 
For Formulary supplements assistance visit  http://portal.aku.edu/pharmacy/olf.asp or Call 34861504/1506
Thank you in advance for your feedback! Link: https://forms.gle/FCo9ZuE4CConzFp46
A Question From Toxicology| American Academy of Clinical Toxicology 
Bilal Ahmad, Pharmacist
 
Question: Ingestion of what toxicant has been associated with feces and vomitus with a blue-green hue?
The signs and symptoms associated with boric acid ingestion are relatively 
non-specific	and	usually	include	nausea,	vomiting	and	diarrhea.	In	addition	
to “boiled lobster” (appearance) skin rash followed by desquamation, feces 
and vomitus have been reported to have a blue-green hue.
Boiled Lobster ( Skin Rash) appearance
What is boric acid used for? 
Boric acid is used in the manufacture of ceramics, glass, and pesticides, as an antiseptic 
for burns, and for treatment of vulvovaginal candidiasis. Accidental ingestions have 
been reported globally, most commonly in children. In a large retrospective series of 
cases	from	two	poison	centers,	the	median	age	of	affected	patients	was	2	years,	and	80%	
of	the	cases	were	in	patients	younger	than	6	years	of	age.	However,	13.5%	of	affected	
patients were adults. Adult exposure may be accidental or intentional. If the vaginal 
capsules taken orally then the above mentioned  symptoms may occur. So special counselling (How to administer) and 
Auxillary labels ( Not For oral use ) is mandatory. 
References:














COVID-19 Pandemic, It’s Time to get back on track with Children’s 
Immunization
Since the start of the pandemic, there has been a troubling drop in routine childhood vaccinations, because families are not 
going to the Hospitals, due to fear of infection.
We know too well the devastating consequences that diseases, like whooping cough and measles, can have on children 
and their families. It is tragic to see a child become sick, or even die, from a disease that we can prevent with safe and 
effective	 vaccines.	 In	 our	 fight	 against	 the	COVID-19	 pandemic,	we	 cannot	 let	 down	 our	 guard	 against	 preventable	
childhood diseases. Now is the time to get every child back on track with recommended vaccines. SO GET YOUR CHILD 
VACCINATED NOW.
For details contact, 021-34861573, 1504
Or visit our Immunization Services (Community Health Centre Pharmacy and Outreach Pharmacies).
